Nutreco and Olympic Investments co-led a $49.8m round for the mycoprotein ingredient developer and University of Strathclyde spinout that included Axa.
Enough, a UK-based mycoprotein producer spun out of University of Strathclyde, raised €42m ($49.8m) today in series B funding today.
The round was co-led by animal nutrition specialist Nutreco and Olympic Investments, the private investment arm of the Onassis Foundation.
The round also featured Axa IM Alts, which is part of insurance group Axa and which invested through its Axa Impact Fund-Climate & Biodiversity vehicle, alongside HAL Investments and Tailored Solutions, Scottish Enterprise and CPT Capital, which remains…
